Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GRIN2D | O15399 | 5/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 5/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 5/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 5/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 5/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
| ▸ | GLB1 | P16278 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7126992 | 1.00 | CA1 (0.40) | CA1CA2CA4TDP1PABPC1 | |
| SCHEMBL10773607 | 0.93 | CA1 (0.35) | CA1CA2CA4TDP1CYP1A2 | |
| SCHEMBL24906364 | 0.91 | TDP1 (0.41) | CA1CA2CA4TDP1PABPC1 | |
| SCHEMBL1985934 | 0.91 | TDP1 (0.41) | CA1CA2CA4TDP1PABPC1 | |
| SCHEMBL10771181 | 0.89 | CA1 (0.34) | CA1CA2CA4TDP1 | |
| SCHEMBL18543687 | 0.89 | CA1 (0.34) | CA1CA2CA4TDP1 | |
| SCHEMBL13766711 | 0.87 | CA1 (0.60) | CA1CA2CA4TDP1PABPC1 | |
| SCHEMBL18543673 | 0.87 | CA1 (0.33) | CA1CA2CA4TDP1 | |
| SCHEMBL15973362 | 0.86 | GLB1 (0.32) | GLB1 | |
| SCHEMBL31645217 | 0.83 | CA1 (0.62) | CA1CA2CA4TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098118-A1 | Non-Softening Thermoplastic Polyurethanes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2026-04-09 | — | — | US | claimed |
| EP-4590733-A1 | NON-SOFTENING THERMOPLASTIC POLYURETHANES | Lubrizol Advanced Materials, Inc. (US) | 2025-07-30 | — | — | EP | claimed |
| CN-119968412-A | Non-softening thermoplastic polyurethane | 路博润先进材料公司 | 2025-05-09 | — | — | CN | claimed |
| CN-115279851-B | Hyperbranched polyester polyol suitable for organic solvent-based two-component polyurethane coating compositions | 巴斯夫欧洲公司 | 2024-07-19 | — | — | CN | claimed |
| WO-2024064070-A1 | NON-SOFTENING THERMOPLASTIC POLYURETHANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| US-20240026072-A1 | Polyester-based Resin Composition | KOLON ENP, INC. (KR) | 2024-01-25 | — | — | US | claimed |
| EP-4245789-A1 | POLYESTER-BASED RESIN COMPOSITION | Kolon Plastics, Inc. (KR) | 2023-09-20 | — | — | EP | claimed |
| CN-116601205-A | Polyester resin composition | 可隆塑胶株式会社 | 2023-08-15 | — | — | CN | claimed |
| US-20230085525-A1 | HYPERBRANCHED POLYESTER POLYOLS SUITABLE FOR USE IN ORGANIC SOLVENT-BASED TWO-COMPONENT POLYURETHANE COATING COMPOSITIONS | BASF SE (DE) | 2023-03-16 | — | — | US | claimed |
| EP-4107231-A1 | HYPERBRANCHED POLYESTER POLYOLS SUITABLE FOR USE IN ORGANIC SOLVENT-BASED TWO-COMPONENT POLYURETHANE COATING COMPOSITIONS | BASF SE (DE) | 2022-12-28 | — | — | EP | claimed |
| US-20030143404-A1 | Articles having a photochromic polymeric coating | TRANSITIONS OPTICAL LIMITED (IE) | 2003-07-31 | — | — | US | claimed |
| US-20030136948-A1 | Photochromic polymerizable compositions | TRANSITIONS OPTICAL LIMITED (IE) | 2003-07-24 | — | — | US | claimed |
| EP-0925321-B1 | PREPOLYMERS CONTAINING MALEIMID FUNCTIONS, METHOD OF PRODUCING AND USE THEREOF | CRAY VALLEY SA (FR) | 2002-06-12 | — | — | EP | claimed |
| US-6306923-B1 | Ultraviolet or visible light polymerizable and/or crosslinkable maleimide-functional coating compositions | SARTOMER COMPANY, INC. | 2001-10-23 | — | — | US | claimed |
| US-6271339-B1 | REACTING A MALEIMIDE WITH A PRIMARY AMINE HAVING AT LEAST ONE OTHER REACTIVE GROUP TO FORM A A MALEAMIC ACID, PARTIALLY CYCLIZING, AND REACTING PRODUCT WITH A POLYFUNCION COMPOUND. | SARTOMER COMPANY, INC. | 2001-08-07 | — | — | US | claimed |
| EP-0925320-B1 | COATING COMPOSITIONS POLYMERISABLE AND/OR CROSS-LINKABLE BY ULTRAVIOLET OR VISIBLE LIGHT | CRAY VALLEY SA (FR) | 2001-01-24 | — | — | EP | claimed |
| EP-0925321-A1 | PREPOLYMERS CONTAINING MALEIMID FUNCTIONS, METHOD OF PRODUCING AND USE THEREOF | CRAY VALLEY SA (FR) | 1999-06-30 | — | — | EP | claimed |
| EP-0925320-A1 | COATING COMPOSITIONS POLYMERISABLE AND/OR CROSS-LINKABLE BY ULTRAVIOLET OR VISIBLE LIGHT | CRAY VALLEY SA (FR) | 1999-06-30 | — | — | EP | claimed |
| WO-1998011152-A1 | COATING COMPOSITIONS POLYMERISABLE AND/OR CROSS-LINKABLE BY ULTRAVIOLET OR VISIBLE LIGHT | CRAY VALLEY S.A. (FR) | 1998-03-19 | — | — | WO | claimed |
| WO-1998011151-A1 | PREPOLYMERS CONTAINING MALEIMID FUNCTIONS, METHOD OF PRODUCING AND USE THEREOF | CRAY VALLEY S.A. (FR) | 1998-03-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098118-A1 | Non-Softening Thermoplastic Polyurethanes | PUF60, DCLRE1A, LRBA | CA1 1131/4885CA2 2786/4885CA4 985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.